Free Access
Med Sci (Paris)
Volume 29, Number 12, Décembre 2013
Page(s) 1071 - 1073
Section Nouvelles
Published online 20 December 2013
  1. Toledo F, Wahl GM. Regulating the p53 pathway : in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006 ; 6 : 909–923. [CrossRef] [PubMed] [Google Scholar]
  2. DP Lane. Cancer. p53, guardian of the genome. Nature 1992 ; 358 : 15–16. [CrossRef] [PubMed] [Google Scholar]
  3. Foord OS, Bhattacharya P, Reich Z, Rotter V. A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res 1991 ; 19 : 5191–5198. [CrossRef] [PubMed] [Google Scholar]
  4. Simeonova I, Jaber S, Draskovic I, et al. Mutant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep 2013 ; 3 : 2046–2058. [CrossRef] [PubMed] [Google Scholar]
  5. Hoareau-Aveilla C, Henry Y, Leblanc T. La dyskératose congénitale. Med Sci (Paris) 2008 ; 24 : 390–398. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Le Guen T, Jullien L, Schertzer M, et al. RTEL1 (regulator of telomere elongation helicase 1), une hélicase d’ADN essentielle à la stabilité du génome. Med Sci (Paris) 2013 ; 29 : 1138–1144. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Brady CA, Attardi LD. p53 at a glance. J Cell Sci 2010 ; 123 : 2527–2532. [CrossRef] [PubMed] [Google Scholar]
  8. Lacroix M, Linares LK, Le Cam L. Rôle du suppresseur de tumeur p53 dans le contrôle du métabolisme. Med Sci (Paris) 2013 ; 29 : 1125–1130. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992 ; 356 : 215–221. [CrossRef] [PubMed] [Google Scholar]
  10. Marine JC, Francoz S, Maetens M, et al. Keeping p53 in check : essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 2006 ; 13 : 927–934. [CrossRef] [PubMed] [Google Scholar]
  11. Liu G, Parant JM, Lang G, et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 2004 ; 36 : 63–68. [CrossRef] [PubMed] [Google Scholar]
  12. Fang M, Simeonova I, Bardot B, et al. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival. Oncogene, 2013 ; doi : 10.1038/onc.2013.62.2013. [Google Scholar]
  13. García-Cao I, García-Cao M, Martín-Caballero J. et al. EMBO J 2002 ; 21 : 6225–6235. [CrossRef] [PubMed] [Google Scholar]
  14. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002 ; 415 : 45–53. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.